XML 70 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Non-financial assets and liabilities - Summary of Carrying Value of In Process Research and Development Acquired by Product (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development $ 576,564 $ 577,183 $ 578,652
In-process research and development acquired      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development 427,779 427,779 $ 427,779
In-process research and development acquired | Cardiovascular Products      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development 254,351 254,351  
In-process research and development acquired | Intravenous products for metabolic diseases and inflammatory/immunologic conditions      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development 70,730 70,730  
In-process research and development acquired | MSC Products      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development $ 102,698 $ 102,698